企業プロフィール
Freeline Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- FRLN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United Kingdom and traded in the U
株価変動の要因
Current closing-price context is not available for FRLN.
企業概要
事業概要
Freeline Therapeutics was a gene-therapy company focused on treating serious diseases through AAV-based gene delivery. Its story centered on whether a gene-therapy platform could create durable value in rare disease.
所在地とセクター分類
Freeline was headquartered in the United Kingdom and traded in the U.S. market. It sat in gene therapy and rare-disease biotechnology.
ビジネスモデルの特徴
The company depended on clinical proof, manufacturing readiness, and capital efficiency in a tough gene-therapy environment. Investors watched data, safety, and strategic optionality.
バイオ業界での位置付け
Freeline occupies a historical gene-therapy niche within biotech. It was highly sensitive to platform validation because the market needed evidence that the approach could scale.
今後のカタリスト
- Freeline is now a legacy / closeout story, with catalysts limited to any residual transaction or asset-resolution update. There is no active standalone pipeline story left.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。